Industry Trends

Practices › PharmaceuticalsNorth American Drug Delivery Technologies Market


North American Drug Delivery Technologies Market


Healthcare
Pharmaceuticals

The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Factors such as rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements are driving the growth of the North American drug delivery technologies market. However, risk of needlestick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years.

Based on the route of administration, the North American drug delivery technologies market is segmented into oral, pulmonary, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. The topical drug delivery market is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the advantages of topical drugs, such as convenience and ease of use, right dosage to the right place, painless application, noninvasive nature, superior spreadability, and enhanced patient compliance.

On the basis of type, the oral drug delivery technologies market is segmented into solid, liquid, and semi-solid drug delivery. Solid oral drug delivery is segmented into tablets, capsules, pills, and powders. In 2016, tablets are estimated to account for the largest share of the solid oral drug delivery market. High patient compliance and acceptability are the major factors driving the growth of this market segment.

The injectable drug delivery market is segmented into two broad categories, namely, devices and formulations. Devices are further subsegmented into conventional and self-injectors, while formulations are further categorized into conventional, novel, and long-acting. In 2016, novel drug delivery formulations are expected to account for the largest share of the formulations market. Enhanced efficacy, increased patient compliance by decreasing dose frequency, and targeted drug delivery (which reduces side effects) are some of the key factors driving the growth of this market segment.

Topical drug delivery is segmented into solid, liquid, semi-solid, and transdermal drug delivery. Transdermal drug delivery is expected to register the highest CAGR during the forecast period. The noninvasive nature of this drug delivery system, feasibility of self-administration, and improved patient compliance are the major factors driving the growth of the transdermal drug delivery market.

Based on end users, the drug delivery technologies market in North America is segmented into hospitals, ambulatory surgical centers (ASCs)/clinics, home care settings, and other end users. The home care settings segment is expected to register the highest CAGR during the forecast period. Improving patient acceptability, patient awareness, and the need for comfortable usability have increased the use of drug delivery systems in home care settings, thus contributing to the growth of this end-user segment.

 North American Drug Delivery Technologies Market

The North American drug delivery technologies market is segmented into the U.S. and Canada. The U.S. is expected to continue to dominate the market during the forecast period. The large share of the U.S. in the North American market can primarily be attributed to factors such as rising prevalence of chronic diseases; rapid growth in the geriatric population; growth in the biologics market; and increasing number of regulatory approvals, new product launches, and technological advancements.

Key players in this market include Johnson & Johnson, Inc. (U.S.), Merck & Co. Inc. (U.S.), Novartis AG (Switzerland), Bayer AG (Germany), 3M Company (U.S.), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson and Company (U.S.), GlaxoSmithKline (U.K.), Pfizer, Inc. (U.S.), Antares Pharma (U.S.), and Sanofi (France).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

We can help find ?

Latent demand for you, for your prospective client, or your prospective partners